After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Tarsus Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Tarsus Pharmaceuticals Inc is $2.14B. A total of 0.69 million shares were traded on the day, compared to an average of 651.60K shares.
In the most recent transaction, Azamian Bobak R. bought 6,000 shares of TARS for 50.00 per share on Mar 24 ’25. In a previous transaction on Mar 18 ’25, Mottiwala Aziz sold 3,643 shares at 46.29 per share. TARS shares that Chief Commercial Officer owns now total 71,979.
Among the insiders who sold shares, Mottiwala Aziz disposed of 3,365 shares on Mar 20 ’25 at a per-share price of $50.11. This resulted in the Chief Commercial Officer holding 65,057 shares of TARS after the transaction. In another insider transaction, Mottiwala Aziz sold 3,557 shares at $47.40 per share on Mar 19 ’25. Company shares held by the Chief Commercial Officer now total 68,422.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, TARS has a high of $57.28 and a low of $20.08.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. TARS’s latest balance sheet shows that the firm has $171.81M in Cash & Short Term Investments as of fiscal 2021. There were $1.89M in debt and $11.48M in liabilities at the time. Its Book Value Per Share was $5.85, while its Total Shareholder’s Equity was $166.73M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TARS is Buy with a score of 4.78.
